Overview

Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of an anti-inflammatory drug (Lotemax®) on the surface of the eye and tear film (a film that coats the eye which is made up of oil and water).
Phase:
N/A
Details
Lead Sponsor:
University of Rochester
Collaborator:
Bausch & Lomb Incorporated
Treatments:
Loteprednol Etabonate